CME Accredited MDS-Foundation Nurse Course
Course 1: Basic introduction to MDS as a disease and management
Cindy Murray, RN, MN, NP-adult
Sandra Kurtin, PhD, ANP-C, AOCN,
Watch Time: 61 minutes
(1) CME Credit
Learn about the biology, diagnosis and management of myelodysplastic syndromes (MDS) including disease classification, prognostication and the patient-centered approach to the treatment of MDS.
CME Accredited MDS-Foundation Nurse Course
Course 2: The future of treating MDS
Geke Ong, RN
Ashley Moncrief, RN
Amber Thomassen, APRN-BC, AOCNP
Watch Time: 70 minutes
(1) CME Credit
Learn about commonly used agents in MDS, as well as novel therapies on the horizon and the impact of these on the nurse’s role in supporting patients with MDS.
CME Accredited MDS-Foundation Nurse Course
Course 3: The role of the nurse in MDS – practical tips for supporting patients and their caregivers
Sara Tinsley-Vance, PhD, APRN
Rebecca Dring, RN, Post Grad Dip. in Cancer Nursing
Jacqueline Jagger, G. Dip BA (HONS), MN NP
Watch Time: 116 minutes
(1) CME Credit
Learn about the MDS therapeutic journey and the role of the nurse in considering quality of life, curative and palliative care - illustrated through patient case studies.
Expert Presentation
The diagnosis & prognosis of AML
John Bennett, MD
Watch Time: 44 mins
Learn about the current diagnostic and prognostic landscape in acute myeloid leukemia (AML), including risk stratification based on cytogenetics and genetic mutations, key morphologic and diagnostic criteria and disease subtyping according to WHO and FAB classification systems.
Expert Presentation
The diagnosis & prognosis of MDS
John Bennett, MD
Watch Time: 53 mins
Take a historical journey from the origins of MDS and learn about the core disease characteristics, the diagnostic and prognostic landscape, the evolution of MDS classification and advances in the understanding of molecular mutations.
Expert Presentations
Novel therapies in acute myeloid leukemia
Eunice Wang, MD
Jeffrey Lancet, MD
Curtis Lachowiez, MD
Eytan Stein, MD
Watch Time: 23 mins
Learn about the latest emerging research and promising advances in the treatment and management of acute myeloid leukemia (AML) presented at ASH 2020.
Expert Presentations
Measurable residual disease in acute lymphoblastic leukemia
Lori Muffly, MD, MS
Nicholas Short, MD
Josep-Maria Ribera, MD, PhD
Watch Time: 40 mins
Watch leading experts discuss recent data on the use and importance of measurable residual disease (MRD) assessment in guiding therapeutic decisions in patients with acute lymphoblastic leukemia (ALL) presented at ASH 2020.
